Cholestech Form 8-K (7-23-03)
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


     
Date of Report (Date of earliest event reported)   July 23, 2003
   

CHOLESTECH CORPORATION

(Exact name of registrant as specified in its charter)
         
California   000-20198   94-3065493
 
 
(State or other jurisdiction
of incorporation)		   (Commission File Number)   (I.R.S. Employer
Identification No.)
         
  3347 Investment Boulevard, Hayward, California     94545
  (Address of principal executive offices)     (Zip Code)
     
Registrant’s telephone number, including area code   (510) 732-7200
 
 
Not applicable
(Former name or former address, if changed since last report)

 

TABLE OF CONTENTS

ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9. REGULATION FD DISCLOSURE (Information furnished pursuant to Item 12 — Results of Operations and Financial Condition)
SIGNATURES
Index to Exhibits
EXHIBIT 99.1

Table of Contents

ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

     (c)  Exhibits.

     
Exhibit No.   Description
 
99.1   Press Release of Cholestech Corporation dated July 23, 2003

ITEM 9. REGULATION FD DISCLOSURE (Information furnished pursuant to Item 12 — Results of Operations and Financial Condition)

     On July 23, 2003, Cholestech Corporation (“Cholestech”) is issuing a press release and holding a conference call regarding its financial results for the fiscal quarter ended June 27, 2003. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.

     The information in this Form 8-K and the exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.

 

Table of Contents

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
Dated: July 23, 2003     CHOLESTECH CORPORATION  
         
         
  By:   /s/ William W. Burke  
     
 
      William W. Burke  
      Vice President of Finance, Chief Financial Officer,  
      Treasurer and Secretary  

 

Table of Contents

Index to Exhibits

     
Exhibit No.   Description
 
99.1   Press Release of Cholestech Corporation dated July 23, 2003